Impact of emergency department opioid use on future health resource utilization among patients with migraine
Objective The purpose of this study was to evaluate the subsequent health resource utilization (HRU) between patients with migraine who received opioid medications at their emergency department (ED) visits (“opioid recipients”) versus patients with migraine who did not receive opioid medications at...
Gespeichert in:
Veröffentlicht in: | Headache 2021-02, Vol.61 (2), p.287-299 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective
The purpose of this study was to evaluate the subsequent health resource utilization (HRU) between patients with migraine who received opioid medications at their emergency department (ED) visits (“opioid recipients”) versus patients with migraine who did not receive opioid medications at their ED visits (“non‐recipients”).
Background
Previous studies have found that opioid use is common among patients with migraine at emergency settings. Medication overuse, especially the use of opioids, is associated with migraine progression, which can ultimately lead to substantial health resource use and costs. There is limited evidence on opioid use specifically in emergency settings and its impact on future HRU among people with migraine.
Method
This retrospective cohort study used electronic health record data from the Baylor Scott & White Health between December 2013 and April 2017. Adult patients who had at least 6 months of continuous enrollment before (baseline or pre‐index) and after (follow‐up) the first date they had an ED visit with a diagnosis of migraine (defined as index date) were enrolled in the study. Opioid use and HRU during follow‐up period between opioid recipients and non‐recipients were summarized and compared.
Results
A total of 788 patients met the eligibility criteria and were included in this study. During the 6‐month follow‐up period, compared to patients with migraine who were non‐recipients at their index ED visits, opioid recipients had significantly more all‐cause (3.6 [SD = 6.3] vs. 1.9 [SD = 4.8], p |
---|---|
ISSN: | 0017-8748 1526-4610 |
DOI: | 10.1111/head.14071 |